Microbot Medical Inc MBOT:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
7.93quote price arrow down-0.56 (-6.60%)
Volume
175,430
52 week range
4.30 - 12.20

...

Loading . . .

KEY STATS

  • Open8.49
  • Day High8.59
  • Day Low7.59
  • Prev Close8.49
  • 52 Week High12.20
  • 52 Week High Date08/17/20
  • 52 Week Low4.30
  • 52 Week Low Date03/16/20
  • Market Cap56.38M
  • Shares Out7.11M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta4.28
  • 1 Year % Change-6.82

RATIOS/PROFITABILITY

  • EPS (TTM)-1.35
  • P/E (TTM)-5.89
  • Fwd P/E (NTM)-5.92
  • EBITDA (MRQ)-8.357M
  • ROE (MRQ)-51.11%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Microbot Medical Inc News

There is no recent news for this security.

Latest MBOT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms, ViRob, TipCAT and Liberty, including certain CardioSert assets, are comprised of proprietary technologies. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCSTM) for the treatment of hydrocephalus and Normal...
Harel Gadot
Chairman
David Ben Naim
Chief Financial Officer
Simon Sharon
Chief Technology Officer
Address
25 RECREATION PARK DR SUITE 108
Hingham, MA
02043
United States